From the eleventh exhibition CPHI, we can understand that: reflect trading conditions, bulk drug raw material price movements fatigue, cardiovascular drugs 54 times growth in exports, but the alarming decline in the prices; exports are raw materials, drugs, low-end products are the main features not changed.
According to the China Chamber of Commerce health care monitoring and statistics, last year's pharmaceutical raw materialsexports grew 39.53%, exports increased by 31.31%, the average export price fell 5.89%. Which, VC export price fell by more than 30%, cephalosporins are not very optimistic about the situation in foreign trade. In contrast, the VE, VB, and tetracycline, etc., the market demand increases, prices rise. Overall, China's API serious structural defects, the industry chain adjustment is imminent.
This, VC of the situation is not optimistic. In addition to the current DSM VC foreign manufacturers are in China, but a serious oversupply. Although last year has spread to the implementation of VC limited production, the quota given to the provinces. Like so worried and VC companies products are antibiotics, especially cephalosporins. With several major pharmaceutical companies of 7-ACA projects have started production, production capacity will add 7600 tons during the year, although the actual production capacity has not been fully realized, but export prices have plummeted.
And VC, 7-ACA prices runs counter to the species is VE, VB, and penicillin products. Health Insurance Association statistics show that exports of penicillin products average price in April rose 7.69% ,6-APA further increase the proportion of 1 to 4 months total export volume and export volume increased by 8.91% and 7.99%. Reporters also found in the CPHI meeting 4AA, 6-APA and the price relative to the 7-ACA in terms of steady rebound in business analysis, this is the first two prices have been low, has no room to fall without no relationship.
Limited power, raw material prices, environmental pressures and other factors are the causes of the rising cost of doing business. Overall, China's API exports to maintain prices, but prices are not rose. Large variety of cyclical excess capacity to export low-end products is the main short-term situation is difficult to change. "
Varieties in China's exports last year, the average price of over $ 100 / kg of a 27, accounting for 12.11% the proportion of all species, but the exports accounted for only 5.59%. The average price of over $ 500 varieties, 60% of export volume growth, 80% of the average price rose varieties, reflecting the high-end products in the market stable, but the proportion of low-end API. 47% of the average export price of raw materials, types of drugs in the 10 U.S. dollars / kg, indicating low levels of homogeneity, low-cost competition highlights.
The export tax rebate is that the enterprises of great concern. In the Health Insurance Association's "China and the World: Medicine Summit was to improve the quality of goods-cum-trade policy interpretation will be", there should be high-tech companies make high value-added tax rebates difference between exports of bulk drugs, bulk drugs, but because most comprehensive code for the Customs Code, the regulatory institutions said, raising the export tax rebate is more difficult, companies should still work in other areas, this can not place too much hope.
Another concern is that in 2010 India has replaced the U.S. as China's largest Chia seed export destination API, the API imports from China more than the average price of European and American countries. This reflects India's downstream API products or brand has advantages. Chinese raw material medicine, India to do preparations, channels and brands in Western countries do, this has not changed. China is now the API is also the ring into her arms, but still in most low-end chain.
Pharmaceutical bulk drugs exports to China mainly to low-end products is difficult to change the structure, large varieties of cyclical downturn in the price situation has not changed, the business risk remains significant. API serious structural defects in the industry, companies should lower the value chain development, but in the current national policy and funding support to a considerable degree of support is not the case, this situation will continue for the short term. General rise in the cost of the case, the export price can not sync up, API China will adversely affect the potential for trade, is worrying.Source:http://www.cospcn.com
The application of tungsten in various industries
Steel Industry Most of tungsten applied in the production of special steels. The widely used high-speed steel was containing 9-24% of tungsten, 3.8-4.6% of chromium, 1-5% of vanadium, 4-7% of cobalt, 0.7-1.5% of carbon.
Magic effects of coconut oil
According to records, coconut oil can be regarded as the nobility of skin care plant extracts. It was rich in exotic tension of tropical plants, which can enhance the contractile force of the pores, perfectly beautify and nourish the skin.
Exploring the Potentials of Nano-Aluminum Powder
Nano-aluminum powder, a material with remarkable properties due to its minuscule particle size, is revolutionizing various industries with its high reactivity and large specific surface area. Unlike its bulk counterpart, nano-aluminum powder begins to oxidize at a lower temperature of 550°C, compared to the 950°C oxidation point of ordinary aluminum. This lower ignition energy and full combustion without apparent cohesion make it a superior choice for applications requiring high energy and efficiency. The unique characteristics of nano-aluminum powder, such as faster burning rates and greater heat release, are largely influenced by its synthesis method, which determines its particle size, surface area, and shape.
